CSIMarket Company Name, Ticker, Industry, else..
 
Sionna Therapeutics Inc   (NASDAQ: SION)
 
Price: $7.4800 $0.18 2.466%
Day's High: $7.550000190734863 Week Perf: 2.33 %
Day's Low: $ 7.17 30 Day Perf: 66.22 %
Volume (M): 766,134 52 Wk High: $ 54.97
Volume (M$): $ 0 52 Wk Avg: $35.82
Open: $7.25 52 Wk Low: $4.01



 Market Capitalization (Millions $) 338
 Shares Outstanding (Millions) 45
 Employees 59
 Revenues (TTM) (Millions $) -
 Net Income (TTM) (Millions $) -97
 Cash Flow (TTM) (Millions $) 22
 Capital Exp. (TTM) (Millions $) 0

Business Description


The company is a clinical-stage biopharmaceutical firm developing medicines to treat cystic fibrosis by normalizing the function of the CFTR protein. Its pipeline includes small molecule NBD1 stabilizers and complementary CFTR modulators targeting the F508del CFTR mutation. The company is advancing multiple candidates through clinical trials to restore CFTR function and improve clinical outcomes for people with cystic fibrosis.


   Company Address: 21 Hickory Drive, Suite 500, Waltham, 2451 MA
   Company Phone Number: 819-2020   Stock Exchange / Ticker: NASDAQ SION


   

Stock Performances by Major Competitors

5 Days Decrease / Increase
     
• View Complete Report
   



Clinical Study

Sionna Therapeutics Announces Presentation of SION-719 and SION-451 Phase 1 Data and Poster of New Preclinical Data o...

Published Fri, Oct 24 2025 6:31 PM UTC

Advanced Insights from Sionna Therapeutics: Promising Phase 1 Data Revealed at the 2025 North American Cystic Fibrosis ConferenceAt the recent 2025 North American Cystic Fibrosis Conference, Sionna Therapeutics made significant waves within the medical and scientific communities by unveiling key findings from their Phase 1 trials of two novel compounds: SION-719 and SION-45...



Fundamental Analysis

Valuation Current
Price to Earnings PE Ratio (TTM) -
Price to Earnings PE Ratio (Expected) -
Price to Sales (TTM) -
Price to Sales (Expected) -
Price to Book 1.27
PEG (TTM) -

Financial Strength Current
Quick Ratio 24.88
Working Capital Ratio 25.36
Leverage Ratio (MRQ) 0.07
Total Debt to Equity -
Interest Coverage (TTM) -
Debt Coverage (TTM) -

Per Share Current
Earnings (TTM) -2.23 $
Revenues (TTM) -
Cash Flow (TTM) 0.49 $
Cash 5.94 $
Book Value 5.89 $
Dividend (TTM) 0 $

Efficiency Current
Revenue per Employee (TTM) -
Net Income per Employee (TTM) -1,650,559
Receivable Turnover Ratio (TTM) -
Inventory Turnover Ratio (TTM) -
Asset Turnover Ratio (TTM) -

Profitability Ratios Current
Gross Margin (MRQ) -
Operating Margin (MRQ) -
Net Margin (MRQ) -
Net Cash Flow Margin (MRQ) -
Effective Tax Rate (TTM) -

Management Effectiveness Current
Return On Assets (TTM) -
Return On Investment (TTM) -
Return On Equity (TTM) -
Dividend Yield -
Pay out Ratio (TTM) -






Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.